CollPlant Biotechnologies Ltd — Form D

CollPlant Biotechnologies Ltd of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-09. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (43)

Showing 25 of 43 people.

NameRoleLocation
Gili HartDirectorRehovot, L3
Abraham HavronDirectorRehovot, L3
Elan PennDirectorRehovot, L3
Roger PomerantzDirectorCardiff, CA
Joseph ZarzewskyDirectorRehovot, L3
Ilana BelzerExecutive OfficerRehovot, L3
Nadav OrrExecutive OfficerRehovot, L3
Elan PennRelated PersonRehovot, L3
Roger Dreiher PomerantzDirectorRehovot, L3
Hugh Dreiher EvansDirectorRehovot, L3
Yehiel TalDirectorRehovot, L3
Yehiel TalExecutive OfficerRehovot, L3
Yehiel TalRelated PersonRehovot, L3
Hadas Dreiher HorowitzExecutive OfficerRehovot, L3
Abraham Dreiher HavronDirectorRehovot, L3
Elana GazalExecutive OfficerRehovot, L3
Alisa Dreiher LaskDirectorRehovot, L3
Philippe BensimonExecutive OfficerRehovot, L3
Philippe BensimonRelated PersonRehovot, L3
Eran RotemExecutive OfficerRehovot, L3
Eran RotemRelated PersonRehovot, L3
Joseph Dreiher ZarzewskyDirectorRehovot, L3
Oren FahimipoorExecutive OfficerRehovot, L3
Oren FahimipoorRelated PersonRehovot, L3
Elan Dreiher PennDirectorRehovot, L3

Other filings by this issuer (5)

FiledFormOfferingSold
2026-07-20D$10.4M$10.4M
2026-02-17D$4.0M$4.0M
2025-06-04D$3.9M$3.9M
2019-09-10D$3.5M$3.5M
2017-11-03D$5.0M$2.0M

More